Cargando…
A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer
A randomized trial was conducted to determine whether administration of Amifostine with chemotherapy for small cell lung cancer could decrease the toxicity. 84 patients with small cell lung cancer of favourable prognosis (limited disease, performance status 0–1; limited disease with performance stat...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2001
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363622/ https://www.ncbi.nlm.nih.gov/pubmed/11139307 http://dx.doi.org/10.1054/bjoc.2000.1539 |